These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. MHC presentation via autophagy and how viruses escape from it. Gannage M; Münz C Semin Immunopathol; 2010 Dec; 32(4):373-81. PubMed ID: 20857294 [TBL] [Abstract][Full Text] [Related]
44. Defective presentation of endogenous antigen by a cell line expressing class I molecules. Hosken NA; Bevan MJ Science; 1990 Apr; 248(4953):367-70. PubMed ID: 2326647 [TBL] [Abstract][Full Text] [Related]
46. Lipopeptides: a novel antigen repertoire presented by major histocompatibility complex class I molecules. Morita D; Sugita M Immunology; 2016 Oct; 149(2):139-45. PubMed ID: 27402593 [TBL] [Abstract][Full Text] [Related]
47. Antigen presentation requires transport of MHC class I molecules from the endoplasmic reticulum. Cox JH; Yewdell JW; Eisenlohr LC; Johnson PR; Bennink JR Science; 1990 Feb; 247(4943):715-8. PubMed ID: 2137259 [TBL] [Abstract][Full Text] [Related]
48. Determination of the cytotoxic T cell epitopes of mouse hepatitis virus, using elution of viral peptides from class I MHC molecules as an approach. Heemskerk MH; Schoemaker HM; Alphen HE; van der Zee R; Joosten I; Spaan WJ; Boog CJ Adv Exp Med Biol; 1993; 342():407-12. PubMed ID: 7516109 [No Abstract] [Full Text] [Related]
49. Presentation of CMV immediate-early antigen to cytolytic T lymphocytes is selectively prevented by viral genes expressed in the early phase. Del Val M; Münch K; Reddehase MJ; Koszinowski UH Cell; 1989 Jul; 58(2):305-15. PubMed ID: 2473842 [TBL] [Abstract][Full Text] [Related]
50. In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine. Deres K; Schild H; Wiesmüller KH; Jung G; Rammensee HG Nature; 1989 Nov; 342(6249):561-4. PubMed ID: 2586628 [TBL] [Abstract][Full Text] [Related]
51. Class II major histocompatibility complex-restricted T cells specific for a virion structural protein that do not recognize exogenous influenza virus. Evidence that presentation of labile T cell determinants is favored by endogenous antigen synthesis. Eisenlohr LC; Hackett CJ J Exp Med; 1989 Mar; 169(3):921-31. PubMed ID: 2784481 [TBL] [Abstract][Full Text] [Related]
52. Reassociation with beta 2-microglobulin is necessary for Kb class I major histocompatibility complex binding of exogenous peptides. Rock KL; Rothstein LE; Gamble SR; Benacerraf B Proc Natl Acad Sci U S A; 1990 Oct; 87(19):7517-21. PubMed ID: 2217182 [TBL] [Abstract][Full Text] [Related]
57. Mechanisms of viral interference with MHC class I antigen processing and presentation. Yewdell JW; Bennink JR Annu Rev Cell Dev Biol; 1999; 15():579-606. PubMed ID: 10611973 [TBL] [Abstract][Full Text] [Related]
58. Cationic lipids direct a viral glycoprotein into the class I major histocompatibility complex antigen-presentation pathway. Walker C; Selby M; Erickson A; Cataldo D; Valensi JP; Van Nest GV Proc Natl Acad Sci U S A; 1992 Sep; 89(17):7915-8. PubMed ID: 1518813 [TBL] [Abstract][Full Text] [Related]
59. Cellular studies on antigen presentation by class II MHC molecules. Unanue ER Curr Opin Immunol; 1992 Feb; 4(1):63-9. PubMed ID: 1596369 [TBL] [Abstract][Full Text] [Related]
60. Measles virus transmembrane fusion protein synthesized de novo or presented in immunostimulating complexes is endogenously processed for HLA class I- and class II-restricted cytotoxic T cell recognition. van Binnendijk RS; van Baalen CA; Poelen MC; de Vries P; Boes J; Cerundolo V; Osterhaus AD; UytdeHaag FG J Exp Med; 1992 Jul; 176(1):119-28. PubMed ID: 1613454 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]